Applications published 20 July 2011
Selected patent applications from the weekly European Patents Bulletin
- Transdermal delivery
Agile Therapeutics; Rossi, Thomas 2343964*
- Methods of using sustained release aminopyridine compsns
Acorda Therapeutics 2343976*
- Substituted aryl sulphone derivatives as calcium channel blockers
Merck Sharp & Dohme 2343977*
- Stabilised compsn for treating psoriasis
Nexmed Holdings 2343978*
- Transdermal delivery
Agile Therapeutics; Rossi, Thomas 2343979*
- Triazole antifungal agents
Wu, Nian; Keller, Brian 2343980*
- Glyphosate formulations containing amidoalkylamine surfactants
Monsanto Technology 2343981*
- Pharmaceutical compsns and related methods of delivery
Chiasma 2343982*
- Method for processing biomaterials
Ultraseptics; Cartwright, Gary; Drozd, James; Simunovic, Josip 2343983*
- Vaginal pellets comprising debranched starch
Henkel 2344121*
- Implantable device for the delivery of octreotide and methods of use thereof
Endo Pharmaceuticals Solutions 2344122*
- Long term drug delivery devices with polyurethane-based polymers and their manufacture
Endo Pharmaceuticals Solutions 2344123*
- Implantable device for the delivery of risperidone and methods of use
Endo Pharmaceuticals Solutions 2344124*
- Implantable device for the delivery of histrelin and methods of use thereof
Endo Pharmaceuticals Solutions 2344125*
- Method and treatment of COPD and other pulmonary diseases
Activaero 2344126*
- Medical devices with definable porosity produced by bacterial polymer bio-synthesis
Sofradim Productions 2344127*
- Ophthalmic administration of a compsn including brimonidine as a mist
Pharmalight 2344128*
- Aerosol fluoroquinolone formulations for improved pharmacokinetics
Mpex Pharmaceuticals 2344129*
- Pharmaceutical topical compsns
Ferrer International 2344130*
- Decomposable biocompatible hydrogels and system and method for using same
Envision Technologies 2344131*
- Liposomal systems comprising sphingomyelin
Yissum Research Development Company of the Hebrew University of Jerusalem 2344132*
- A compsn of matter comprising liposomes embedded in a polymeric matrix and methods of using same
Yissum Research Development Company of the Hebrew University of Jerusalem 2344133*
- Nanocarriers for drug delivery
The Regents of the University of California 2344134*
- A process for making particles for delivery of drug nanoparticles
Nanomaterials Technology 2344125*
- Pharmaceutical dosage forms comprising poly(E-caprolactone)
Purdue Pharma 2344136*
- Method for making cetirizine tablets
McNeil-PPC 2344137*
- Use of polyether-based and vinyl monomer-based copolymers as binders for solid dosage forms comprising solid active ingredients
BASF 2344138*
- Method for delivering a pharmaceutical compsn to patient in need thereof
AstraZeneca 2344139*
- A method for the production of bioadhesive compact matrices
Universita’ Degli Studi Genova 2344140*
- compsns comprising amlodipine and bisoprolol
Egis Gyógyszergyár Nyilvánosan Mukodo Részvénytársaság 2344141*
- Treatment of pervasive developmental disorders with redox-active therapeutics
Edison Pharmaceuticals 2344142*
- Bioactive compsn for the treatment of HIV/AIDS, method for manufacturing and use the same
Shukla, Mukesh 2344143*
- 1-amino-alkylcyclohexan derivatives for the treatment of cognitive impairment in tinnitus
Merz Pharma 2344144*
- Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods
Gilead Sciences 2344145*
- Use of anti-connexin agents for modulating the therapeutic affect of psychotropic drugs
Commisariat à l’Énergie Atomique et aux Énergies Alternatives 2344146*
- Nutritional support of the immune system during anti-cancer treatment
Nestec 2344147*
- Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
Nestec 2344148*
- Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
Centre National de la Recherche Scientifique 2344149*
- Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumour
Nestec; Institut Curie 2344150*
- Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
House Ear Institute; Otonomy; Friedman, Rick; Vollrath, Benedikt 2344151*
- Oral vaccines for producing mucosal toxicity
Immune Solutions 2344152*
- Compound useful for treating cellulite
Sigma-Tau Industrie Farmaceutiche Riunite 2344153*
- Compsns that include anthocyanidins and methods of use
Maqui New Life 2344154*
- Compsn and method for treating dry eye syndrome
Ramscor 2344155*
- Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent
Nerviano Medial Sciences 2344156*
- Novel inhibitors
Probiodrug 2344157*
- Use of isoQC inhibitors
Probiodrug 2344158*
- Medicaments and methods for inhibition of scarring
Renovo 2344159*
- Tryptophan hydroxylase inhibitors and methods of their use
Lexicon Pharmaceuticals 2344160*
- Water-soluble camptothecin with cetuximab or bevacizumab
Celator Pharmaceuticals 2344161*
- 5HT7 receptor ligands and compsns comprising the same
Laboratoires del Dr Esteve 2344162*
- Oral formulation
H Lundbeck 2344163*
- Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for the treatment of myeloma
Bayer Schering Pharma 2344164*